EuBiologics Co., Ltd. (KOSDAQ:206650)

South Korea · Delayed Price · Currency is KRW

9,460.00

+320.00 (3.50%)

Jun 12, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Pharmaceuticals	96.04B	69.37B	55.47B	39.38B	28.49B
Pharmaceuticals Growth	38.45%	25.06%	40.83%	38.24%	-
Total	96.04B	69.37B	55.47B	39.38B	28.49B
Total Growth	38.45%	25.06%	40.83%	38.24%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
South Korea	2.51B	4.47B	4.42B	4.15B
South Korea Growth	-43.93%	1.13%	6.41%	-
Overseas	66.86B	51.00B	34.96B	24.34B
Overseas Growth	31.11%	45.85%	43.68%	-
Total	69.37B	55.47B	39.38B	28.49B
Total Growth	25.06%	40.83%	38.24%	-